Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Cosfroviximab (c13C6-FR1) is a chimeric monoclonal antibody derived from mouse and human sources, designed to target the Ebola virus glycoprotein (EBOV-GP) [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry |
Description | Cosfroviximab (c13C6-FR1) is a chimeric monoclonal antibody derived from mouse and human sources, designed to target the Ebola virus glycoprotein (EBOV-GP) [1]. |
Molecular Weight | N/A |
CAS No. | 1792982-57-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Cosfroviximab 1792982-57-0 inhibitor inhibit